Federated Hermes, Inc. Sangamo Therapeutics, Inc Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$0.42 - $1.38 $2,341 - $7,692	-5,574 Reduced 1.64%	335,119 $224,000
Q4 2023 Jan 31, 2024	SELL	$0.3 - $0.63 $30,976 - $65,050	-103,255 Reduced 23.26%	340,693 $183,000
Q3 2023 Nov 13, 2023	BUY	$0.58 - $1.47 $1,747 - $4,429	3,013 Added 0.68%	443,948 $266,000
Q2 2023 Aug 14, 2023	BUY	$1.11 - $1.74 $134,197 - $210,364	120,899 Added 37.78%	440,935 $573,000
Q1 2023 May 08, 2023	BUY	$1.66 - $3.67 $296,321 - $655,120	178,507 Added 126.13%	320,036 $563,000
Q4 2022 Feb 13, 2023	SELL	$2.77 - $5.07 $532,549 - $974,737	-192,256 Reduced 57.6%	141,529 $444,000
Q3 2022 Nov 14, 2022	SELL	$4.27 - $6.39 $1.69 Million - $2.53 Million	-395,565 Reduced 54.24%	333,785 $1.64 Million
Q2 2022 Aug 15, 2022	SELL	$3.28 - $6.21 $1.16 Million - $2.2 Million	-354,854 Reduced 32.73%	729,350 $3.02 Million
Q1 2022 May 13, 2022	BUY	$5.23 - $7.82 $3.14 Million - $4.69 Million	599,932 Added 123.88%	1,084,204 $6.3 Million
Q4 2021 Feb 14, 2022	BUY	$7.29 - $10.97 $3.47 Million - $5.22 Million	476,288 Added 5965.53%	484,272 $3.63 Million
Q3 2021 Nov 15, 2021	BUY	$9.01 - $12.01 $71,935 - $95,887	7,984 New	7,984 $72,000
Q3 2018 Nov 13, 2018	SELL	$13.05 - $19.05 $18,100 - $26,422	-1,387 Closed	0 $0
Q2 2018 Aug 10, 2018	SELL	$13.9 - $19.8 $5.91 Million - $8.42 Million	-425,435 Reduced 99.68%	1,387 $19,000
Q1 2018 May 09, 2018	BUY	$16.7 - $26.35 $2.24 Million - $3.54 Million	134,389 Added 45.96%	426,822 $8.11 Million
Q4 2017 Feb 14, 2018	BUY	$11.6 - $17.35 $1.34 Million - $2.01 Million	115,639 Added 65.41%	292,433 $0
Q3 2017 Nov 13, 2017	BUY	$8.4 - $15.0 $1.49 Million - $2.65 Million	176,794	176,794 $2.65 Million

Others Institutions Holding SGMO

# of Institutions

111

Shares Held

56.4M

Call Options Held

576K

Put Options Held

1.17M

Wasatch Advisors Inc Salt Lake City, UT

19.4M
Shares

$22.4 Million
0.08% of portfolio
Vanguard Group Inc Valley Forge, PA

9.6M
Shares

$11 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

4.85M
Shares

$5.58 Million
0.01% of portfolio
Black Rock Inc. New York, NY

4.7M
Shares

$5.41 Million
0.0% of portfolio
Marshall Wace, LLP London, X0

2.35M
Shares

$2.71 Million
0.0% of portfolio

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $180M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account